Catalyst Wire Dossier Catalyst Wire Dossier

ZIRABEV

BEVACIZUMAB-BVZR · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ZIRABEV, covering 2019-06-27 to 2026-03-25. Get the full timeline:

Most recent: EMA Authorised: Zirabev (bevacizumab) — Pfizer Europe MA EEIG

See pricing